Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Recurrent ASXL1 Mutations Promote Myeloid Malignancies through Unleashed Condensation

Maria Latacz, Yansu Song, Yi Hao, Marta Cykowiak, Julia Kirylczuk, Jing Hu, Bi Shi, Hao Jiang

Blood (2024) 144 (Supplement 1): 42.

https://doi.org/10.1182/blood-2024-204634

Published: 2024

Journal Articles

Dynamic Changes in ABL1 Kinase Domain Mutations and Comparative Efficacy of Third-Generation Tyrosine Kinase Inhibitors across Different Stages in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Blast Crisis Patients

Zixuan Li, Danyue Peng, Jun Deng, Lv Xiong, Ping Yin, Jing Hu, Chenjing Qian, Lan Yao, Hua Yin, Mei Hong, Qiuling Wu

Blood (2023) 142 (Supplement 1): 4207.

https://doi.org/10.1182/blood-2023-188208

Published: 2023

Journal Articles

IST Combined with Full-Dose Rhtpo in the Treatment of Severe Aplastic Anemia -a Prospective Single-Center Clinical Study

Huihui Fan, Jing Hu, Wenrui Yang, Xin Zhao, Li Zhang, Kang Zhou, Youzhen Xiong, Liping Jing, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 4086.

https://doi.org/10.1182/blood-2023-182717

Published: 2023

Journal Articles

Targeting the Dpy30 Subunit of Set1/Mll Complexes to Inhibit MLL-Rearranged Leukemogenesis

Kushani Shah, BS, Zhenhua Yang, PhD, Robert Whitaker, Theodore Busby, Jing Hu, PhD, William Placzek, PhD, Hao Jiang, PhD

Blood (2016) 128 (22): 3933.

https://doi.org/10.1182/blood.V128.22.3933.3933

Published: 2016

Journal Articles

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Paul M. Barr, Gene B. Saylors, Stephen E. Spurgeon, Bruce D. Cheson, Daniel R. Greenwald, Susan M. O’Brien, Andre K. D. Liem, Rosemary E. Mclntyre, Adarsh Joshi, Esteban Abella-Dominicis, Michael J. Hawkins, Anita Reddy, Julie Di Paolo, Hank Lee, Joyce He, Jing Hu, Lyndah K. Dreiling, Jonathan W. Friedberg

Blood (2016) 127 (20): 2411–2415.

https://doi.org/10.1182/blood-2015-12-683516

Published: 2016

Includes: Supplemental data

Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Julie Di Paolo, PhD, Clarence Eng, MPH, Jing Hu, PhD, Jing He, Anita Reddy, PhD, Christopher A. Yasenchak, MD

Blood (2015) 126 (23): 4152.

https://doi.org/10.1182/blood.V126.23.4152.4152

Published: 2015

Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Indolent Non-Hodgkin's Lymphoma (iNHL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Clarence Eng, MPH, Jing He, Jing Hu, PhD, Christopher A. Yasenchak, MD

Blood (2015) 126 (23): 1545.

https://doi.org/10.1182/blood.V126.23.1545.1545

Published: 2015

Journal Articles

Role of the Dpy30 Subunit of Set1/Mll Complexes in Lymphomagenesis through Epigenetic Regulation of Myc Activity

Zhenhua Yang, PhD, Kushani Shah, Jonathan Augustin, Jing Hu, PhD, Hao Jiang, PhD

Blood (2015) 126 (23): 310.

https://doi.org/10.1182/blood.V126.23.310.310

Published: 2015

Journal Articles

Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of B-Cell Receptor Pathway Signaling

Jeff P. Sharman, MD, Andrei R. Shustov, MD, Mitchell R. Smith, MD PhD, Thomas E. Boyd, MD, Christopher Hagenstad, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Jing He, Clarence Eng, MPH, Jing Hu, PhD, Anita Reddy, PhD, Siddhartha Mitra, MDPhD, Christopher A. Yasenchak, MD, Farrukh T. Awan, MD MS

Blood (2015) 126 (23): 1744.

https://doi.org/10.1182/blood.V126.23.1744.1744

Published: 2015

Journal Articles

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Jeff Sharman, Michael Hawkins, Kathryn Kolibaba, Michael Boxer, Leonard Klein, Meihua Wu, Jing Hu, Steve Abella, Chris Yasenchak

Blood (2015) 125 (15): 2336–2343.

https://doi.org/10.1182/blood-2014-08-595934

Published: 2015

Includes: Supplemental data

Journal Articles

Regulation of Hematopoietic Stem and Progenitor Cell Fate Determination By the Dpy30 Subunit of Set1/Mll Complexes

Zhenhua Yang, PhD, Jonathan Augustin, BA, Jing Hu, PhD, Hao Jiang, PhD

Blood (2014) 124 (21): 767.

https://doi.org/10.1182/blood.V124.21.767.767

Published: 2014

Journal Articles

The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells

Zhenhua Yang, Jonathan Augustin, Chenbei Chang, Jing Hu, Kushani Shah, Chia-Wei Chang, Tim Townes, Hao Jiang

Blood (2014) 124 (13): 2025–2033.

https://doi.org/10.1182/blood-2014-01-549220

Published: 2014

Includes: Multimedia, Supplemental data

Journal Articles

Phase 2 Trial Of GS-9973, a Selective Syk Inhibitor, In Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)

Jeff P. Sharman, MD, Leonard Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Michael J. Hawkins, MD, Julie A Di Paolo, PhD, Jing Hu, Ph.D, Anita Reddy, PhD, Feng Jin, PhD, Flordeliza Melchor-Khan, BS, Christopher A. Yasenchak, MD

Blood (2013) 122 (21): 1634.

https://doi.org/10.1182/blood.V122.21.1634.1634

Published: 2013

Journal Articles

Role Of Dpy30/MLL Complexes In Regulating Hematopoietic Progenitor Cell Maintenance and Differentiation

Zhenhua Yang, PhD, Jonathan Augustin, BA, Jing Hu, PhD, Chia-Wei Chang, PhD, Tim M. Townes, PhD, Hao Jiang, PhD

Blood (2013) 122 (21): 2424.

https://doi.org/10.1182/blood.V122.21.2424.2424

Published: 2013

Journal Articles

Early and Permanent Telomere Shortening in Bone Marrow-Derived Cells Following Chemotherapy: A Parallel Study In Vivo in Lymphoma Patients and In Vitro in Cultured Mesenchymal Stem Cells

Angela Gueli, MD, Marco Ruella, MD, Alessandra Risso, PhD, Tiziana Spatola, PhD, Hui Jing Hu, MD, Daniela Gottardi, MD, Alberto De Crescenzo, MD, Stefano Buttiglieri, PhD, Corrado Tarella, MD

Blood (2011) 118 (21): 1620.

https://doi.org/10.1182/blood.V118.21.1620.1620

Published: 2011

Journal Articles

Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589).

Rong Lin, MD, Jing Hu, PhD, Sofia Paul, PhD, Joanne Schindler, Margaret M. Woo, Stan Spence, PhD, Samit Hirawat, MD, Harald A. Weber, MD

Blood (2009) 114 (22): 2740.

https://doi.org/10.1182/blood.V114.22.2740.2740

Published: 2009

Journal Articles

Molecular basis of biomaterial-mediated foreign body reactions

Wen-Jing Hu, John W. Eaton, Tatiana P. Ugarova, Liping Tang

Blood (2001) 98 (4): 1231–1238.

https://doi.org/10.1182/blood.V98.4.1231

Published: 2001

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Recurrent ASXL1 Mutations Promote Myeloid Malignancies through Unleashed Condensation

Dynamic Changes in ABL1 Kinase Domain Mutations and Comparative Efficacy of Third-Generation Tyrosine Kinase Inhibitors across Different Stages in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Blast Crisis Patients

IST Combined with Full-Dose Rhtpo in the Treatment of Severe Aplastic Anemia -a Prospective Single-Center Clinical Study

Targeting the Dpy30 Subunit of Set1/Mll Complexes to Inhibit MLL-Rearranged Leukemogenesis

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Indolent Non-Hodgkin's Lymphoma (iNHL)

Role of the Dpy30 Subunit of Set1/Mll Complexes in Lymphomagenesis through Epigenetic Regulation of Myc Activity

Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of B-Cell Receptor Pathway Signaling

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Regulation of Hematopoietic Stem and Progenitor Cell Fate Determination By the Dpy30 Subunit of Set1/Mll Complexes

The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells

Phase 2 Trial Of GS-9973, a Selective Syk Inhibitor, In Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)

Role Of Dpy30/MLL Complexes In Regulating Hematopoietic Progenitor Cell Maintenance and Differentiation

Early and Permanent Telomere Shortening in Bone Marrow-Derived Cells Following Chemotherapy: A Parallel Study In Vivo in Lymphoma Patients and In Vitro in Cultured Mesenchymal Stem Cells

Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589).

Molecular basis of biomaterial-mediated foreign body reactions

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only